Searched for
ZYDUS LIFE TARGET PRICE
Life advice of the day by Helen Keller: 'Life is a succession of lessons which must be...'- A timeless life lesson on why life must be lived before it can truly be understood by a woman of astounding intelligenceHelen Keller's life powerfully illustrates that true wisdom stems from lived experiences, not just knowledge acquisition. Overcoming profou...- Best Proverb of the Day by Albert Einstein: “There are only two ways to live your life. One is as though nothing is a miracle. The other is as though everything is a miracle.”Best Proverb of the Day: Albert Einstein's profound insight reveals life's dual nature: either viewed as ordinary or as a series of miracle...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Life Lesson of the Day by Albert Einstein: 'Logic will get you from A to B. Imagination will...' Learnings on rational thinking, true innovation and endless possibilitiesLife Lesson of the Day by Albert Einstein reminds people that logic helps solve known problems, while imagination creates new possibilities...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...
- Hot Stocks: 2 stocks that may give returns between 16-19%Leading brokerages CLSA and Morgan Stanley have initiated coverage on Vedanta Aluminium and Adani Enterprises, respectively, signaling sign...
- NFO Update: Tata AIA Life Insurance launches Multifactor Index FundTata AIA Life Insurance has launched the Tata AIA Multifactor Index Fund, a ULIP-based offering designed to combine equity market participa...
- Nomura cuts target price of this AI, data centre beneficiary company. Here’s whyNomura remains positive on Anant Raj despite trimming earnings estimates and lowering its target price due to slower cloud ramp-up and proj...
- Angel One, CAMS and ICICI AMC among JP Morgan's preferred bets on India's SIP boomJP Morgan has initiated coverage of India’s capital markets sector with a bullish outlook, citing resilient SIP inflows and rising retail f...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Life lesson of the day by Diogenes: 'As a matter of self-preservation, a man needs good friends or ardent enemies, for the...' - thought-provoking quote by Greek philosopher and founder of the Cynic school teaches why you need both friends and enemies in lifeLife lesson of the day by Diogenes: Ancient Greek philosopher Diogenes believed that both friends and enemies are crucial for personal grow...
- Should investors buy the dip in Vedanta shares after 9% slide? Analysts weigh inVedanta shares fell on Tuesday after promoter entity Twin Star Holdings reportedly sold around 7.3 crore shares (1.7% stake) worth ₹2,149 c...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...
- Sell or Hold: Citi maintains buy on Cipla; Motilal Oswal recommends buy on RIL post AGMBrokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...
- NFO Alert: Zerodha Fund House launches 2 target-date Life Cycle fundsZerodha Fund House has launched India’s first target-date Life Cycle Fund series, offering two schemes: 2036 and 2041 maturities. The NFO i...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
Load More
